Bio Path logo

Bio Path share price today

(BPTH)

Bio Path share price is $1.04 & ₹88.61 as on 25 Dec 2024, 2.30 'hrs' IST

$1.04

-0.07

(-6.31%)

Market is closed - opens 8 PM, 26 Dec 2024

View live Bio Path share price in Dollar and Rupees. Guide to invest in Bio Path from India. Also see the sentimental analysis on Indian investors investing in Bio Path. Get details on the Indian mutual funds that are investing in Bio Path. Get Analyst recommendations and forecasts along with all the Bio Path's financials.

Bio Path share price movements

  • Today's Low: $0.96
    Today's High: $1.09

    Day's Volatility :11.93%

  • 52 Weeks Low: $0.59
    52 Weeks High: $12.00

    52 Weeks Volatility :95.06%

Bio Path Returns

PeriodBio Path Holdings IncIndex (Russel 2000)
3 Months
11.83%
0.0%
6 Months
-46.67%
0.0%
1 Year
-89.9%
0.0%
3 Years
-75.12%
-21.1%

Bio Path Key Statistics

in dollars & INR

Previous Close
$1.11
Open
$1.1
Today's High
$1.0901
Today's Low
$0.96
Market Capitalization
$4.8M
Today's Volume
$706.9K
52 Week High
$12.0
52 Week Low
$0.593263
Revenue TTM
$0.0
EBITDA
$-13.0M
Earnings Per Share (EPS)
$-8.34
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-366.18%

How to invest in Bio Path from India?

It is very easy for Indian residents to invest directly in Bio Path from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Bio Path stock in both Indian Rupees (INR) and US Dollars (USD). Search for Bio Path or BPTH on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Bio Path or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Bio Path shares which would translate to 0.819 fractional shares of Bio Path as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Bio Path, in just a few clicks!

Returns in Bio Path for Indian investors in Rupees

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Bio Path investment value today

Current value as on today

₹12,533

Returns

₹87,467

(-87.47%)

Returns from Bio Path Stock

₹89,893 (-89.89%)

Dollar Returns

₹2,426 (+2.43%)

Indian investors sentiment towards Bio Path

3675.0%

Period: Sep 26, 2024 to Dec 25, 2024. Change in 30 Days versus previous period

Investment in Bio Path from India has grown in the last 30 days as on Dec 26, 2024. 3675.0% more purchase transactions for Bio Path in the last 30 days versus the previous period.

615%

Period: Sep 26, 2024 to Dec 25, 2024. Change in 30 Days versus previous period

Search volume for Bio Path on INDmoney from India has grown in the last 30 days as on Dec 26, 2024. 615% more investors are searching Bio Path in the last 30 days versus the previous period.

Global Institutional Holdings in Bio Path

  • Geode Capital Management, LLC

    0.32%

  • Vanguard Group Inc

    0.31%

  • Citadel Advisors Llc

    0.25%

  • Tower Research Capital LLC

    0.08%

  • UBS Group AG

    0.07%

  • BlackRock Inc

    0.06%

Analyst Recommendation on Bio Path

Buy

    85%Buy

    14%Hold

    0%Sell

Based on 7 Wall street analysts offering stock ratings for Bio Path(by analysts ranked 0 to 5 stars)

Based on 7 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
6
6
6
Hold
1
1
1
Sell
0
0
0

Analyst Forecast on Bio Path

What analysts predicted

Upside of 1053.85%

Current:

$1.04

Target:

$12.00

Insights on Bio Path

  • Price Movement

    In the last 7 days, BPTH stock has moved up by 55.5%
  • BPTH vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 27.3% return, outperforming this stock by 117.0%
  • BPTH vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 25.2% return, outperforming this stock by 101.6%

Bio Path Technicals Summary

Sell

Neutral

Buy

Bio Path is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Bio Path Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Bio Path Holdings Inc
29.27%
-46.67%
-89.9%
-75.12%
-86.97%
Regeneron Pharmaceuticals, Inc.
-4.68%
-32.01%
-18.29%
12.56%
91.19%
Biontech Se
-5.49%
41.99%
6.11%
-55.22%
226.93%
Alnylam Pharmaceuticals, Inc.
-3.08%
-1.52%
23.75%
50.98%
112.09%
Vertex Pharmaceuticals Incorporated
-11.59%
-13.61%
0.03%
83.58%
86.41%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Bio Path Holdings Inc
NA
NA
0.0
-3.17
-3.66
-1.4
NA
0.71
Regeneron Pharmaceuticals, Inc.
17.7
17.7
1.06
45.07
0.17
0.07
NA
272.04
Biontech Se
160.8
NA
0.04
-3.11
-0.02
-0.01
NA
79.73
Alnylam Pharmaceuticals, Inc.
NA
NA
-0.49
-0.19
-15.01
-0.03
NA
0.25
Vertex Pharmaceuticals Incorporated
32.84
NA
1.06
0.51
-0.03
0.12
NA
60.65
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Bio Path Holdings Inc
Buy
$4.8M
-86.97%
NA
0.0%
Regeneron Pharmaceuticals, Inc.
Buy
$78.6B
91.19%
17.7
33.61%
Biontech Se
Buy
$27.2B
226.93%
160.8
-15.36%
Alnylam Pharmaceuticals, Inc.
Buy
$31.2B
112.09%
NA
-15.86%
Vertex Pharmaceuticals Incorporated
Buy
$104.4B
86.41%
32.84
-4.51%

About Bio Path

bio-path is a publicly traded biotechnology company focused on developing therapeutic products utilizing its proprietary dnabilize™ technology designed to distribute nucleic acid drugs throughout the human body with a simple intravenous infusion. the company’s initial focus is in oncology. bio-path’s lead product candidate, prexigebersen, (bp1001), is in phase ii clinical trials for aml in combination with ldac in elderly de novo patients. the safety segment of the phase ii trial for prexigebersen + dasatinib in blast-phase and accelerated phase cml patients is expected to begin in 2017. bio-path’s second drug candidate, bp1002, is ready for the clinic where it will be evaluated in lymphoma and solid tumors. the technology behind prexigebersen is called dnabilize™ technology. dnabilize is a liposomal antisense dna platform with two critical improvements in oligonucleotide therapeutics. the main benefits to the patient are, 1: we have never had a single patient experience thrombocytopen
Organization
Bio Path
Employees
10
CEO
Mr. Peter H. Nielsen MBA
Industry
Health Technology

Management People of Bio Path

NameTitle
Mr. Peter H. Nielsen MBA
Co-Founder, Chairman of the Board, CEO, President, CFO & Treasurer
Mr. Douglas P. Morris
Co-Founder, Director of Investor Relations, Secretary & Director
Mr. Michael Hickey M.B.A.
VP of Clinical Operations
Mr. Anthony Price
Senior Vice President of Finance, Accounting & Administration
Dr. Ana Tari Ashizawa M.B.A., MBA, Ph.D.
Senior Vice President of Research, Development & Clinical Design

Important FAQs about investing in Bio Path from India :

What is Bio Path share price today?

Bio Path share price today stands at $1.04, Open: $1.10 ; Previous Close: $1.11 ; High: $1.09 ; Low: $0.96 ; 52 Week High: $12.00 ; 52 Week Low: $0.59. The stock opens at $1.10, after a previous close of $1.11. The stock reached a daily high of $1.09 and a low of $0.96, with a 52-week high of $12.00 and a 52-week low of $0.59.

Can Indians buy Bio Path shares?

Yes, Indians can invest in the Bio Path (BPTH) from India.

With INDmoney, you can buy Bio Path at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Bio Path at zero transaction cost.

How can I buy Bio Path shares from India?

It is very easy to buy Bio Path from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Bio Path be purchased?

Yes, you can buy fractional shares of Bio Path with INDmoney app.

What are the documents required to start investing in Bio Path stocks?

To start investing in Bio Path, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Bio Path

Today’s highest price of Bio Path (BPTH) is $1.09.

Today’s lowest price of Bio Path (BPTH) is $0.96.

What is today's market capitalisation of Bio Path

Today's market capitalisation of Bio Path BPTH is 4.8M

What is the 52 Week High and Low Range of Bio Path

  • 52 Week High

    $12.00

  • 52 Week Low

    $0.59

What are the historical returns of Bio Path?

  • 1 Month Returns

    29.27%

  • 3 Months Returns

    -46.67%

  • 1 Year Returns

    -89.9%

  • 5 Years Returns

    -86.97%

Who is the Chief Executive Officer (CEO) of Bio Path

Mr. Peter H. Nielsen MBA is the current Chief Executive Officer (CEO) of Bio Path.